Cargando…

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort

AIMS: To examine the number and type of co-morbid long-term health conditions (LTCs) and their associations with all-cause mortality in an atrial fibrillation (AF) population. METHODS AND RESULTS: Community cohort participants (UK Biobank n = 502 637) aged 37–73 years were recruited between 2006 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jani, Bhautesh Dinesh, Nicholl, Barbara I, McQueenie, Ross, Connelly, Derek T, Hanlon, Peter, Gallacher, Katie I, Lee, Duncan, Mair, Frances S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277149/ https://www.ncbi.nlm.nih.gov/pubmed/29112751 http://dx.doi.org/10.1093/europace/eux322

Ejemplares similares

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018)

Risk Factors and Mortality Associated with Multimorbidity in People with Stroke or Transient Ischaemic Attack: A Study of 8,751 UK Biobank Participants
por: Gallacher, Katie I., et al.
Publicado: (2018)

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2018)

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2020)

Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank
por: McQueenie, Ross, et al.
Publicado: (2021)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
por: Corcoran, Neave ME, et al.
Publicado: (2022)

Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort
por: Sullivan, Michael K, et al.
Publicado: (2021)

Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants
por: Marley, Jennifer, et al.
Publicado: (2021)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Social connection and mortality in UK Biobank: a prospective cohort analysis
por: Foster, Hamish M. E., et al.
Publicado: (2023)

Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts
por: Chiang, Jason I., et al.
Publicado: (2020)

Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol
por: Canning, Jordan, et al.
Publicado: (2020)

Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study
por: McLoone, Philip, et al.
Publicado: (2023)

Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
por: Niedzwiedz, Claire L., et al.
Publicado: (2020)

Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
por: Hastie, Claire E., et al.
Publicado: (2023)

Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review
por: Chiang, Jason I., et al.
Publicado: (2018)

Family history of diabetes and risk of SARS‐COV‐2 in UK Biobank: A prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
por: Sullivan, Michael K., et al.
Publicado: (2021)

Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2013)

Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol
por: Chiang, Jason I, et al.
Publicado: (2018)

Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank
por: Petermann-Rocha, Fanny, et al.
Publicado: (2020)

Multimorbidity and the COVID-19 pandemic – An urgent call to action
por: Mair, Frances S, et al.
Publicado: (2020)

The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort
por: Foster, Hamish M. E., et al.
Publicado: (2022)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

Comorbidity versus multimorbidity: Why it matters
por: Harrison, Christopher, et al.
Publicado: (2021)

Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
por: Sullivan, Michael K., et al.
Publicado: (2020)

Multimorbidity and SARS-CoV-2 infection in UK Biobank
por: Chudasama, Yogini V., et al.
Publicado: (2020)

Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
por: Jani, Bhautesh D., et al.
Publicado: (2015)

Response to ‘Multimorbidity and SARS-CoV-2 infection in UK biobank’
por: Sur Roy, Abhipsha, et al.
Publicado: (2020)

Experiences of multimorbidity in urban and rural Malawi: An interview study of burdens of treatment and lack of treatment
por: Chikumbu, Edith F., et al.
Publicado: (2022)

Ethnic differences in the association between depression and chronic pain: cross sectional results from UK Biobank
por: Nicholl, Barbara I., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ij57689200kh2foestfngovq5a